Rollins Inc

Piper Sandler downgraded Rollins Inc to Neutral from Overweight, sending shares down 6.4% Thursday. Analyst Peter Keith cut his price target to $33 from $46, warning that structural technological and competitive shifts could weigh on the pest control giant's long-term organic growth trajectory. The downgrade reflects growing concern over agentic AI search tools, which appear to be steering prospective residential and commercial customers toward smaller, local service providers, while an influx of private equity capital into the pest control space has intensified industry competition. Although Rollins shares have fallen roughly 46% year-to-date and are trading near a 10-year valuation low, Piper Sandler said the stock is likely to remain range-bound until there is clearer visibility on organic revenue momentum, despite potential near-term tailwinds from favorable weather comparisons.

Rollins, Inc. reported second-quarter revenue of US$1.08 billion, up 7.9% year on year but below analyst forecasts, with EBITDA and EPS also falling short of expectations. The company posted net income of US$143.91 million and diluted EPS of US$0.30, both only slightly above last year's levels. CEO Jerry E. Gahlhoff and CFO William W. Harkins discussed the results at the U.S. All Stars Conference in London, where the miss sharpened investor focus on how efficiently Rollins converts revenue into profitability. The shortfall puts added weight on management's efficiency efforts and M&A discipline, given the company's high debt and dependence on acquisitive growth to support its multi-brand pest control model. Rollins' narrative projects US$5.0 billion revenue and US$732.6 million earnings by 2029, while more cautious analysts assume only about 7.2 percent annual revenue growth to US$4.8 billion and earnings of roughly US$698 million by 2029.

Rollins shares have dropped 7.8% since the company reported second-quarter 2026 results that missed the Zacks Consensus Estimate on both earnings and revenues. Adjusted earnings of 32 cents per share missed by 5.9% but rose 6.7% year over year, while total revenues of $1.08 billion fell short by 1.7% but increased 7.9% from the year-ago quarter. Residential revenues increased 6.6% to $485.8 million, commercial revenues climbed 8.6% to $347.9 million, and termite and ancillary revenues rose 10.5% to $234.2 million, though franchise and other revenues declined 7.4% to $10.7 million. Operating margin contracted 110 basis points to 18.7% as costs remained aligned for stronger demand, and management has implemented organizational changes to improve execution after lead volumes improved toward the end of June. The consensus estimate has shifted down 9.4% in the past month, and Rollins currently carries a Zacks Rank #4, or Sell.

Kirby McInerney LLP has launched an investigation into Rollins, Inc. over potential securities fraud. The investigation concerns whether the company or its senior management violated federal securities laws or engaged in unlawful business practices. On July 22, 2026, Rollins reported second-quarter fiscal 2026 results with an operating margin of 18.7%, down 110 basis points year-over-year, and operating cash flow of $173 million, a 1.5% decline. CEO Jerry Gahlhoff stated that results did not meet expectations and that the lead environment worsened during the quarter, with fewer people actively searching for pest control needs. Following the news, Rollins' stock fell $4.03 per share, or 9.27%, to close at $39.44 on July 23, 2026.

Rollins Inc. shares have fallen 38% over the past six months but remain expensive relative to earnings and sector peers, according to Zacks Investment Research. The stock trades at 30.35 times forward 12-month earnings, compared with 17.9 times for the Zacks sector and 20.11 times for the S&P 500 Index. Rollins reported second-quarter 2026 adjusted earnings of 32 cents per share, missing the consensus estimate by 5.9%, while revenues of $1.08 billion missed by 1.7%. Operating margin contracted 110 basis points to 18.7% as demand softened and costs stayed elevated. Zacks assigns a Strong Sell rating and a $33 price target, implying further downside from the recent $39.01 share price.

Rollins, Inc. reported that second-quarter results fell short of expectations as consumer-initiated residential demand weakened, particularly at its Orkin brand, while commercial pest control and termite revenues grew 8.6% and 10.5% respectively. Residential pest control revenue rose only 6.6%, with lead volume declining in search and digital channels, though relationship-based units like HomeTeam and Fox delivered double-digit organic growth. The company completed six acquisitions in the quarter, spending $117 million, and goodwill rose to $1.45 billion. Technology tools improved technician efficiency, with miles driven per vehicle per month improving 8% to offset a 30% rise in fuel costs. Rollins paid $88 million in dividends in the second quarter of 2026, and the stock currently carries a Zacks Rank #5 (Strong Sell).

Glancy Prongay Wolke & Rotter LLP has commenced an investigation into Rollins Inc. for possible violations of federal securities laws. The investigation follows Rollins' July 22, 2026 second-quarter earnings report, which disclosed an operating margin of 18.7%, down 110 basis points year-over-year, and operating cash flow of $173 million, a 1.5% decline. CEO Jerry Gahlhoff stated on the earnings call that results missed expectations and that the lead environment worsened through the quarter, with fewer people actively searching for pest control needs. On this news, Rollins shares fell $4.03, or 9.27%, to close at $39.44 on July 23, 2026. The law firm is urging investors who suffered losses to contact them regarding potential claims.

The Law Offices of Frank R. Cruz has launched an investigation into Rollins, Inc. over potential federal securities law violations. The investigation follows Rollins' July 22, 2026 second-quarter earnings report, which showed an operating margin of 18.7%, down 110 basis points from the prior year, and operating cash flow of $173 million, a 1.5% decline. On the earnings call, CEO Jerry Gahlhoff said results missed expectations and cited a worsening lead environment with fewer people searching for pest control services. Rollins shares fell $4.03, or 9.27%, to close at $39.44 on July 23, 2026, causing investor losses.

JPMorgan downgraded Rollins to Neutral from Overweight and cut its price target to $45 from $70, citing uncertainty around weakening residential demand and a slower-than-expected margin recovery. The brokerage said questions raised at Rollins' investor day outweighed the answers, particularly around the sharp slowdown in consumer-initiated demand and the timing of a margin recovery. JPMorgan analyst Tomohiko Sano lowered fiscal 2026 and 2027 revenue growth forecasts to 8.7% and 8.4%, respectively, while reducing adjusted EBITDA margin estimates to 21.9% and 22.2%. The downgrade follows a weaker-than-expected second quarter, with residential organic growth slowing to 3.6% as brands dependent on search and digital marketing saw declining lead volumes. Management has lowered its 2026 incremental EBITDA margin target to at least 10% from its longer-term framework of 30%-35%, though it expects improvement to be weighted toward the fourth quarter.

US stock futures are pointing lower this morning, with E mini S&P 500 contracts down about 0.4%, as investors react to higher borrowing costs and a jump in market volatility. The US 10 year Treasury yield is sitting near a two month high around 4.65%, raising costs for mortgages, car loans, and business financing, while crude oil strength and geopolitical tensions feed worries that the cost of living could stay elevated for longer. Among top movers, Lockheed Martin jumped 10.54% after Q2 results showed higher sales and net income, United Rentals gained 10.11% following a Q2 beat and higher guidance, and Thermo Fisher Scientific climbed 8.71% on strong Q2 earnings and raised guidance. On the losing side, Tesla fell 14.52% after Q2 earnings and multiple analyst price target cuts, T-Mobile US declined 10.75% despite Q2 revenue growth and a higher price target from Goldman Sachs, and Rollins dropped 9.27% following a downgrade to Underperform. On the radar, earnings from American Express, SLB, Verizon, NextEra Energy, and HCA Healthcare share the spotlight with key US manufacturing data.

Shares of Rollins, North America's largest pest control provider, fell 10% after reporting second-quarter earnings that missed adjusted earnings-per-share expectations despite an 8% sales beat. Organic sales rose 6% in the quarter, and management expects full-year organic revenue growth of 6% plus two to three percentage points from acquisitions. A Bank of America analyst lowered the price target from $55 to $35, citing pressure on the consumer unit and residential organic growth of only 3.6% versus the 5.4% expected. The stock had been trading at 33 times free cash flow, and the results failed to meet lofty expectations, contributing to a 34% decline year-to-date in 2026.

Several major companies saw significant after-hours stock moves following their latest quarterly results. Alphabet shares fell more than 4% after the company raised its 2026 capital expenditures forecast to a range of $195 billion to $205 billion, citing artificial intelligence demand, even as second-quarter revenue of $119.8 billion topped expectations. Tesla dropped 3% after adjusted earnings of 33 cents per share missed estimates by 18 cents, despite revenue of $28.24 billion beating forecasts. IBM rose about 2% even though adjusted earnings of $2.93 per share and revenue of $17.16 billion both slightly missed consensus. ServiceNow gained more than 2% after beating estimates with adjusted earnings of 90 cents per share on revenue of $3.99 billion and raising its full-year subscription revenue outlook. Las Vegas Sands lost 6% after adjusted earnings of 59 cents per share and revenue of $3.15 billion fell short of expectations. United Rentals surged 10% after posting adjusted earnings of $12.76 per share on revenue of $4.41 billion, surpassing estimates, and hiking its full-year revenue guidance to a range of $17.5 billion to $17.8 billion. Medpace Holdings soared about 19% after beating second-quarter estimates and raising full-year guidance. Other notable movers included Rollins, which dropped about 10% on weaker-than-expected results, and Shutterstock, which fell 10% after suspending its quarterly dividend.

Rollins, Inc. is set to report second-quarter 2026 results on July 22 after the closing bell. The Zacks Consensus Estimate for revenues is $1.1 billion, representing a 9.8% year-over-year increase, with residential revenues expected at $494.3 million, commercial at $351.8 million, and termite and ancillary at $240.1 million. Earnings are pegged at 34 cents per share, implying 13.3% growth. However, the company carries an Earnings ESP of -2.94% and a Zacks Rank #4 (Sell), suggesting a potential earnings miss.

Wells Fargo analyst Jason Haas lowered the price target on Rollins to $46 from $55 while maintaining an Equal Weight rating, citing expectations of weaker-than-consensus organic revenue growth in the second quarter of 2026. Haas noted that despite a strong March exit rate, momentum has not held up, particularly in one-time pest control jobs which are more volatile than recurring subscription services. Separately, Rollins announced on May 27 that CFO Kenneth D. Krause resigned effective June 15 to pursue an opportunity in an unrelated industry, and will remain in an advisory capacity through September 30, 2026 under a separation agreement.

William Blair updated its July Analyst Conviction List, adding Oracle, American Express, Ecolab, Comfort Systems USA, Boot Barn, LifeStance Health, Genmab, Silence Therapeutics, Tyra Biosciences, Arxis, Novanta, Dynatrace, Everpure, and ServiceTitan. The firm said Oracle is emerging as a major beneficiary of the AI infrastructure buildout, with hyperscale cloud commitments driving record remaining performance obligations and stronger revenue visibility. Removed stocks included Meta Platforms, Chewy, SharkNinja, Chime, Flywire, LPL Financial, Palomar, Exponent, GFL Environmental, Encompass Health, Waystar, Insmed, LENZ Therapeutics, Ocular Therapeutix, Curtiss-Wright, Mayville Engineering, Standex, Arista Networks, Guidewire, JLL, Procore, and Rubrik, all through automatic six-month removals. Axsome Therapeutics was removed after FDA approval for Auvelity in Alzheimer’s disease agitation and a roughly 48% gain since its April addition, while Rollins was removed as near-term growth and margin trends looked less clear.

Rollins shares have fallen 25.8% over the past six months to a new 52-week low of $45.00 per share, partly due to softer quarterly results. The pest-control company, which operates brands including Orkin and HomeTeam Pest Defense, posted an 11.7% compound annual revenue growth rate over the last five years, outpacing the average industrial company. Rollins also maintained a 52.2% average gross margin and a 16.1% average free cash flow margin over the same period, signaling strong unit economics and cash profitability. Following the decline, the stock trades at 35.1 times forward earnings.